Vusion is owned by Mylan.
Vusion contains Miconazole Nitrate; Petrolatum, White; Zinc Oxide.
Vusion has a total of 1 drug patent out of which 0 drug patents have expired.
Vusion was authorised for market use on 16 February, 2006.
Vusion is available in ointment;topical dosage forms.
Vusion can be used as use for treatment of diaper dermatitis complicated by candidiasis.
The generics of Vusion are possible to be released after 30 March, 2028.
|Patent Number||Company||Patent Title||Patent Expiry||Activity Alert|
|These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).|
|US8147852||MYLAN||Modified azole compounds as antifungal and antibacterial agents|| |
(5 years from now)
Market Authorisation Date: 16 February, 2006
Treatment: Use for treatment of diaper dermatitis complicated by candidiasis
Click on the highlighted region to filter.
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic